A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

3,200

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

September 13, 2022

Study Completion Date

December 13, 2022

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

sIPV vaccine /DTaP vaccine

All subjects received 3 doses of sIPV vaccines and 3 doses of DTaP vaccines. Subjects recommended intramuscular injection. The best site for intramuscular injection is the anterolateral middle thigh for infants and the deltoid muscle for children.

BIOLOGICAL

sIPV vaccine /Hepatitis A inactivated vaccine /MMR vaccine

All subjects will receive 1 dose of sIPV and 2 doses of hepatitis A inactivated vaccine/or 1 dose of attenuated hepatitis A vaccine and 1 dose of MMR vaccine.Subjects recommended intramuscular injection. The best site for intramuscular injection is the anterolateral middle thigh for infants and the deltoid muscle for children.

Trial Locations (2)

330899

Gaoan Center for Disease Control and Prevention, Gao’an

Unknown

Shangli County Center for Disease Control and Prevention, Pingxiang

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY